The price-to-earnings ratio for Elevance Health Inc (NYSE: ELV) is 17.08x, which is above its average ratio. Moreover, the 36-month beta value for ELV is 0.63. Analysts have varying opinions on the stock, with 13 analysts rating it as a “buy,” 5 as “overweight,” 4 as “hold,” and 0 as “sell.”
The public float for ELV is 226.90M and currently, short sellers hold a 1.11% of that float. On April 08, 2025, ELV’s average trading volume was 1.72M shares.
ELV) stock’s latest price update
The stock of Elevance Health Inc (NYSE: ELV) has increased by 3.40 when compared to last closing price of 423.14. Despite this, the company has experienced a 1.12% gain in its stock price over the last five trading sessions. zacks.com reported 2025-04-04 that Elevance Health (ELV) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
ELV’s Market Performance
Elevance Health Inc (ELV) has experienced a 1.12% rise in stock performance for the past week, with a 6.83% rise in the past month, and a 15.25% rise in the past quarter. The volatility ratio for the week is 3.80%, and the volatility levels for the past 30 days are at 2.63% for ELV. The simple moving average for the last 20 days is 1.84% for ELV stock, with a simple moving average of -3.72% for the last 200 days.
Analysts’ Opinion of ELV
Many brokerage firms have already submitted their reports for ELV stocks, with Argus repeating the rating for ELV by listing it as a “Buy.” The predicted price for ELV in the upcoming period, according to Argus is $450 based on the research report published on March 17, 2025 of the current year 2025.
Stephens, on the other hand, stated in their research note that they expect to see ELV reach a price target of $440, previously predicting the price at $520. The rating they have provided for ELV stocks is “Equal-Weight” according to the report published on January 22nd, 2025.
ELV Trading at 6.79% from the 50-Day Moving Average
After a stumble in the market that brought ELV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -22.87% of loss for the given period.
Volatility was left at 2.63%, however, over the last 30 days, the volatility rate increased by 3.80%, as shares surge +3.74% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +6.47% upper at present.
During the last 5 trading sessions, ELV rose by +1.19%, which changed the moving average for the period of 200-days by -18.13% in comparison to the 20-day moving average, which settled at $429.64. In addition, Elevance Health Inc saw 18.60% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at ELV starting from Penczek Ronald W, who sale 443 shares at the price of $415.13 back on Mar 10 ’25. After this action, Penczek Ronald W now owns 1,847 shares of Elevance Health Inc, valued at $183,903 using the latest closing price.
Penczek Ronald W, the Officer of Elevance Health Inc, proposed sale 443 shares at $415.13 during a trade that took place back on Mar 10 ’25, which means that Penczek Ronald W is holding shares at $183,904 based on the most recent closing price.
Stock Fundamentals for ELV
Current profitability levels for the company are sitting at:
- 0.04 for the present operating margin
- 0.47 for the gross margin
The net margin for Elevance Health Inc stands at 0.03. The total capital return value is set at 0.09. Equity return is now at value 14.83, with 5.30 for asset returns.
Based on Elevance Health Inc (ELV), the company’s capital structure generated 0.43 points at debt to capital in total, while cash flow to debt ratio is standing at 0.19. The debt to equity ratio resting at 0.76. The interest coverage ratio of the stock is 6.7.
Currently, EBITDA for the company is 9.09 billion with net debt to EBITDA at 2.26. When we switch over and look at the enterprise to sales, we see a ratio of 0.7. The receivables turnover for the company is 9.27for trailing twelve months and the total asset turnover is 1.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.45.
Conclusion
To wrap up, the performance of Elevance Health Inc (ELV) has been better in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
